By |

Profile

Catalent is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Contact Information

Website: www.catalent.com
Email: investors@catalent.com
Main Phone: +1 732 537-6200
Address: 14 Schoolhouse Road
State: NJ
City / Town: Somerset
Country: USA
Postal Code: 08873

Issuer Information

Exchange: NYE
CEO: John R. Chiminski
Employees: 10700
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Catalent is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Contact Information

Website: www.catalent.com
Email: investors@catalent.com
Main Phone: +1 732 537-6200
Address: 14 Schoolhouse Road
State: NJ
City / Town: Somerset
Country: USA
Postal Code: 08873

Issuer Information

Exchange: NYE
CEO: John R. Chiminski
Employees: 10700
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 35.61 $ 0.40 (1.14%)
Last Price 35.61 Change $ 0.40 Change % 1.14 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 35.44 High 35.95 Low 35.05 Prev Close 35.21
Last Trade Volume 558,531 52 Wk Hi 47.87 52 Wk Low 29.23
Market Cap 5.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 145,371,888.00 EPS (TTM) 0.50 PE Ratio 71.20 Exchange NYSE
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 103
Number of Buys 0 58
Number of Sells 0 45
Net Activity 0 95828
Last 10 Buys Shares
Uwe Roehrhoff 1,000
Donald E. Morel 1,000
Last 10 Sell Shares
William Downie 1,000
John R. Chiminski 1,000
John R. Chiminski 1,000
John R. Chiminski 1,000
Christine Dolan 1,000
Lance Miyamoto 1,000
Christine Dolan 1,000
Matthew M. Walsh 1,000
Matthew M. Walsh 1,000
Sharon Johnson 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 50 50 50 50
Low Target Price Estimate 44 44 44 44
Mean Target Price Estimate 47.44 47.44 47.44 47.44
Standard Deviation 2.01 2.01 2.01 2.01
Date of Most Recent Estimate 06/04/18 05/07/18 05/07/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 3 3 3 2
Hold 4 4 4 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.88 1.88 1.88 2.04